Diarrhea clinical trials

Explore recruiting diarrhea clinical trials.

Recruiting diarrhea studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Diarrhea trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Pilot / Phase 2 Clinical Trial of GSL-01-001 Administered Orally for 12 Weeks Preceded by a 2 Week Screening Period in Patients Presenting with Symptoms Associated with Irritable Bowel Syndrome with code GSL-01-001

Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Phase-II randomized clinical trial to evaluate the effect of Loratadine associated with Rapamune on Lymphagioleiomyomatosis (LAM).

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

A single patient trial with Ataluren in one case of severe common variable immunodeficiency with autoimmunity due to homozygous stop codon mutations of LRBA

Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

Multicenter, Open-label, Single arm, Phase II Clinical Trial to Improve Sacituzumab Govitecan Tolerance in Patients with Metastatic Triple-Negative or Luminal Breast Cancer. – The PRIMED Study –

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Effect of Saccharomyces boulardii CNCM I-745 on gut microbiota in patients undergoing antibiotic therapy (in the context of erythema migrans (early skin form of Lyme borreliosis)

Slovenia, Czechia, Lithuania, Slovakia

Therapeutic use (Phase IV) EU CTIS Study details

PipEracillin Tazobactam versus mERoPENem for treatment of bloodstream infections caused by cephalosporin-resistant Enterobacteriaceae - a non-inferiority randomized controlled trial (PETERPEN)

Italy

Therapeutic use (Phase IV) EU CTIS Study details

Diarrhea trials by city

Diarrhea in Toronto Diarrhea in Vancouver Diarrhea in Montreal Diarrhea in Calgary Diarrhea in Edmonton Diarrhea in Ottawa Diarrhea in Winnipeg Diarrhea in Quebec City Diarrhea in Hamilton Diarrhea in Kitchener Diarrhea in London Diarrhea in Halifax Diarrhea in New York Diarrhea in Los Angeles Diarrhea in Chicago Diarrhea in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease